Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00108394 · ClinicalTrials.gov registry record · Phase 4

Osteopenia and Renal Osteodystrophy: Evaluation and Management

A Phase 4 study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 4
Development phase

NCT00108394: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.

NCT00108394 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00108394, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 4
Development phase

Study Summary

The purpose of this study is to demonstrate whether pamidronate will preserve or increase bone mass in patients with adynamic bone disease, caused by low bone turnover.

Interventions

  • DRUG pamidronate

Trial Details

FieldValue
Start Date 2002-10
Est. Completion 2007-09
Phase Phase 4
US Department of Veterans Affairs

632 total trials

What the finished NCT00108394 record still lists

NCT00108394 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which pamidronate is the first listed.

NCT00108394 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00108394 about?

NCT00108394 is a clinical study titled "Osteopenia and Renal Osteodystrophy: Evaluation and Management". The purpose of this study is to demonstrate whether pamidronate will preserve or increase bone mass in patients with adynamic bone disease, caused by low bone turnover.

What is the current status of trial NCT00108394?

This trial is currently completed. It is a Phase 4 study. The study started on 2002-10. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00108394?

The interventions under investigation include: pamidronate (DRUG).

Who is sponsoring clinical trial NCT00108394?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00108394, the US trial registry maintained by the National Library of Medicine. NCT00108394 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.